BioSyent Inc. (TSXV:RX)
17.45
-0.04 (-0.23%)
Nov 20, 2026, 4:00 PM EST
BioSyent Revenue
BioSyent had revenue of 20.08M CAD in the quarter ending September 30, 2026, with 64.33% growth. This brings the company's total for the last twelve months to 63.54M, up 50.65% year-over-year. In the year 2025, BioSyent had annual revenue of 43.05M with 22.90% growth. That makes BioSyent the 28,876th largest company in the world by revenue and 517th in Canada.
Revenue (ttm)
63.54M
Revenue Growth
+50.65%
P/S Ratio
3.11
Revenue / Employee
n/a
Employees
n/a
Market Cap
197.34M
Revenue by Geography
- Canada 39.01M 90.6%
- Global 3.74M 8.7%
- United States 308.07K 0.7%
Fiscal year ended Dec 31, 2025 See the full BioSyent breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.05M | 8.02M | 22.90% |
| Dec 31, 2024 | 35.03M | 3.44M | 10.89% |
| Dec 31, 2023 | 31.59M | 3.67M | 13.12% |
| Dec 31, 2022 | 27.93M | -693.03K | -2.42% |
| Dec 31, 2021 | 28.62M | 6.29M | 28.15% |
| Dec 31, 2020 | 22.33M | 907.84K | 4.24% |
| Dec 31, 2019 | 21.42M | -102.70K | -0.48% |
| Dec 31, 2018 | 21.53M | 764.27K | 3.68% |
| Dec 31, 2017 | 20.76M | 2.84M | 15.85% |
| Dec 31, 2016 | 17.92M | 2.53M | 16.47% |
| Dec 31, 2015 | 15.39M | 3.18M | 26.02% |
| Dec 31, 2014 | 12.21M | 4.41M | 56.56% |
| Dec 31, 2013 | 7.80M | 2.78M | 55.24% |
| Dec 31, 2012 | 5.02M | 2.22M | 78.88% |
| Dec 31, 2011 | 2.81M | 1.13M | 67.06% |
| Dec 31, 2010 | 1.68M | 651.31K | 63.24% |
| Dec 31, 2009 | 1.03M | -72.09K | -6.54% |
| Dec 31, 2008 | 1.10M | -2.33K | -0.21% |
| Dec 31, 2007 | 1.10M | -650.43K | -37.07% |
| Dec 31, 2006 | 1.75M | 905.99K | 106.74% |
| Dec 31, 2005 | 848.77K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cresco Labs | 924.67M |
| TerrAscend | 379.07M |
| Organigram Global | 309.18M |
| Canopy Growth | 308.32M |
| Medexus Pharmaceuticals | 152.84M |
| Cannara Biotech | 117.33M |
| HLS Therapeutics | 80.76M |
| Cipher Pharmaceuticals | 70.26M |
BioSyent News
- 2 days ago - BioSyent Q3 Profit Rises 7% As Oral Health Acquisition Lifts Sales - Nasdaq
- 3 days ago - BioSyent Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - BioSyent Earnings release: Q3 2026 - Filings
- 3 days ago - BioSyent Report: Q3 2026 - Filings
- 3 days ago - BioSyent MD&A: Q3 2026 - Filings
- 23 days ago - BioSyent Transcript: Planet MicroCap Showcase: Toronto 2026 - Transcripts
- 1 month ago - BioSyent Named as One of Canada's Top Growing Companies 2026 by The Globe and Mail - GlobeNewsWire
- 3 months ago - BioSyent Declares Third Quarter 2026 Dividend - GlobeNewsWire